Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Cardiovasc Pharmacol ; 43(3): 358-68, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15076219

ABSTRACT

The effects of endogenous adenosine and adenosine receptor agonists were examined on hypoxia-induced myocardial stunning of guinea-pig isolated paced left atria and papillary muscles. Hypoxia (30 minutes) reduced developed tension and increased diastolic tension (contracture) of left atria (41.8 +/- 11.5%) and papillary muscles (17.7 +/- 6.2%). Developed tension recovered to 80.8 +/- 3.15 and 77.2 +/- 5.3% 15 minutes after reoxygenation (stunning). Recovery of left atria was unaffected by adenosine deaminase (1 IU mL) but was depressed in papillary muscles (15 minutes, 48.6 +/- 4.3%) and contracture (46.1 +/- 7.5%) increased. Endogenous adenosine therefore protects from ventricular but not atrial stunning. Adenosine receptor agonists were introduced at 10 minutes into hypoxia. CPA (A1 selective, 3 x 10 M) impaired left atrial recovery (5 minutes, 38.1 +/- 5.0%), through direct negative inotropy, but did not affect papillary muscles. CGS21680 (A2A selective, 3 x 10 M) did not affect recovery. APNEA (A1/A3 receptor agonist, 10 M), increased recovery rate of left atria. Improved rate and extent of recovery of papillary muscles by APNEA (15 minutes, 94.8 +/- 3.1%) was prevented by the A3 receptor antagonist, MRS-1220 (10 M). IB-MECA (A3 selective, 3 x 10 M) increased atrial recovery rate but not the maximum developed tension reached in either tissue. However, when added at reoxygenation, IB-MECA caused complete recovery of both tissues, in the absence or presence of adenosine deaminase. Thus, A3 receptor stimulation reverses myocardial stunning of isolated atria and papillary muscles.


Subject(s)
Adenosine/physiology , Heart Atria/drug effects , Hypoxia/drug therapy , Muscle, Smooth, Vascular/drug effects , Myocardial Stunning/prevention & control , Purinergic P1 Receptor Agonists , Adenosine Deaminase/pharmacology , Animals , Guinea Pigs , Hypoxia/complications , Male , Myocardial Stunning/etiology , Papillary Muscles/drug effects
2.
Eur J Pharmacol ; 477(3): 235-45, 2003 Sep 23.
Article in English | MEDLINE | ID: mdl-14522362

ABSTRACT

Guinea pig isolated working hearts were exposed to 30-min ischaemia by reducing coronary flow to 10%, followed by reperfusion. Aortic output fell to 4.5+/-4.5% of the pre-ischaemic value at reperfusion, recovering to 48.2+/-14.6% at 20-min post-reperfusion; the index of myocardial stunning. IB-MECA (N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide, 3 x 10(-7) M), infused from 10 min into ischaemia, did not affect recovery of aortic output 20 min after reperfusion (41.9+/-1.9%). IB-MECA infused at reperfusion, however, significantly protected against stunning, aortic output recovering to 79.6+/-3.9% at 20-min post-reperfusion. Hypoxic gassing (5% CO(2) in nitrogen, 30 min) of guinea pig isolated paced left atria and papillary muscles reduced the developed tension, recovering to 75% 5 min after re-oxygenation. This myocardial stunning was unaffected by IB-MECA (3 x 10(-7) M) added 10 min into hypoxia. IB-MECA added at reoxygenation significantly improved recovery, which was prevented by the adenosine A(3) receptor antagonist, 1-propyl-3-(3-iodo-4-aminobenzyl)-8-(4-oxyacetate)phenylxanthine (I-ABOPX, 1 x 10(-5) M). Thus, stimulation of adenosine A(3) receptors at reperfusion/reoxygenation in guinea pig cardiac preparations protects against myocardial stunning.


Subject(s)
Adenosine A3 Receptor Agonists , Adenosine/analogs & derivatives , Adenosine/therapeutic use , Hypoxia/complications , Myocardial Ischemia/complications , Myocardial Stunning/prevention & control , Adenosine/antagonists & inhibitors , Adenosine/pharmacology , Animals , Coronary Circulation/drug effects , Coronary Circulation/physiology , Endothelium, Vascular/drug effects , Endothelium, Vascular/injuries , Guinea Pigs , Heart Atria/drug effects , Heart Atria/physiopathology , Hypoxia/drug therapy , Male , Myocardial Ischemia/drug therapy , Myocardial Stunning/complications , Myocardial Stunning/drug therapy , Oxygen/pharmacology , Papillary Muscles/drug effects , Papillary Muscles/physiopathology , Perfusion , Receptor, Adenosine A3/physiology , Reperfusion Injury/complications , Reperfusion Injury/drug therapy , Reperfusion Injury/physiopathology , Time Factors , Xanthines/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...